Ignite Creation Date:
2025-12-24 @ 8:01 PM
Ignite Modification Date:
2026-05-18 @ 7:53 AM
Study NCT ID:
NCT04555304
Status:
UNKNOWN
Last Update Posted:
2020-09-18
First Post:
2020-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy
Sponsor:
Chengdu Kanghong Biotech Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
KH903-40101-CRP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None